Baskhanbio Pharma Inc. (XKON:354390)
South Korea · Delayed Price · Currency is KRW 5,210.00
-220.00 (-4.05%)
At close: Oct 2, 2025
Baskhanbio Pharma Market Cap
Baskhanbio Pharma has a market cap or net worth of 36.57 billion as of October 6, 2025. Its market cap has decreased by -17.95% in one year.
Market Cap
36.57B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5,210.00
Market Cap Chart
Since July 20, 2022, Baskhanbio Pharma's market cap has decreased from 82.82B to 36.57B, a decrease of -55.85%. That is a compound annual growth rate of -22.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 36.57B | 21.45% |
| Dec 30, 2024 | 30.11B | -36.91% |
| Dec 28, 2023 | 47.72B | 16.64% |
| Dec 29, 2022 | 40.92B | -50.59% |
| Jul 20, 2022 | 82.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 579.68T |
| SK hynix | 273.06T |
| LG Energy Solution | 93.37T |
| Samsung Biologics | 71.81T |
| Hanwha Aerospace | 56.44T |
| Hyundai Motor Company | 48.05T |
| HD Hyundai Heavy Industries | 46.87T |
| KB Financial Group | 42.53T |